AU1118888A – Conjugate malaria vaccine
– Google Patents
AU1118888A – Conjugate malaria vaccine
– Google Patents
Conjugate malaria vaccine
Info
Publication number
AU1118888A
AU1118888A
AU11188/88A
AU1118888A
AU1118888A
AU 1118888 A
AU1118888 A
AU 1118888A
AU 11188/88 A
AU11188/88 A
AU 11188/88A
AU 1118888 A
AU1118888 A
AU 1118888A
AU 1118888 A
AU1118888 A
AU 1118888A
Authority
AU
Australia
Prior art keywords
conjugate
malaria vaccine
malaria
vaccine
conjugate malaria
Prior art date
1987-02-02
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
AU11188/88A
Other versions
AU624324B2
(en
Inventor
Stanley J. Cryz Jr.
Jerald C. Sadoff
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Cilag GmbH International
Original Assignee
Schweiz Serum und Impfinstitut und Institut zur Erforschung der Infektionskrankheiten
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
1987-02-02
Filing date
1988-02-02
Publication date
1988-08-04
1988-02-02
Application filed by Schweiz Serum und Impfinstitut und Institut zur Erforschung der Infektionskrankheiten
filed
Critical
Schweiz Serum und Impfinstitut und Institut zur Erforschung der Infektionskrankheiten
1988-08-04
Publication of AU1118888A
publication
Critical
patent/AU1118888A/en
1992-06-11
Application granted
granted
Critical
1992-06-11
Publication of AU624324B2
publication
Critical
patent/AU624324B2/en
2008-02-02
Anticipated expiration
legal-status
Critical
Status
Ceased
legal-status
Critical
Current
Links
Espacenet
Global Dossier
Discuss
Classifications
A—HUMAN NECESSITIES
A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
A61K39/00—Medicinal preparations containing antigens or antibodies
A61K39/002—Protozoa antigens
A61K39/015—Hemosporidia antigens, e.g. Plasmodium antigens
A—HUMAN NECESSITIES
A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
A61K39/00—Medicinal preparations containing antigens or antibodies
A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
A61K2039/6031—Proteins
A61K2039/6037—Bacterial toxins, e.g. diphteria toxoid [DT], tetanus toxoid [TT]
A—HUMAN NECESSITIES
A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
A61K39/00—Medicinal preparations containing antigens or antibodies
A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
A61K2039/6031—Proteins
A61K2039/6068—Other bacterial proteins, e.g. OMP
A—HUMAN NECESSITIES
A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
A61K39/00—Medicinal preparations containing antigens or antibodies
A61K2039/62—Medicinal preparations containing antigens or antibodies characterised by the link between antigen and carrier
A61K2039/627—Medicinal preparations containing antigens or antibodies characterised by the link between antigen and carrier characterised by the linker
Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
AU11188/88A
1987-02-02
1988-02-02
Conjugate malaria vaccine
Ceased
AU624324B2
(en)
Applications Claiming Priority (4)
Application Number
Priority Date
Filing Date
Title
US944187A
1987-02-02
1987-02-02
US009441
1987-02-02
US15035988A
1988-01-29
1988-01-29
US150359
1988-01-29
Publications (2)
Publication Number
Publication Date
AU1118888A
true
AU1118888A
(en)
1988-08-04
AU624324B2
AU624324B2
(en)
1992-06-11
Family
ID=26679484
Family Applications (1)
Application Number
Title
Priority Date
Filing Date
AU11188/88A
Ceased
AU624324B2
(en)
1987-02-02
1988-02-02
Conjugate malaria vaccine
Country Status (3)
Country
Link
EP
(1)
EP0289110A3
(en)
AU
(1)
AU624324B2
(en)
CA
(1)
CA1329124C
(en)
Cited By (1)
* Cited by examiner, † Cited by third party
Publication number
Priority date
Publication date
Assignee
Title
AU615181B2
(en)
*
1987-03-30
1991-09-26
Novartis Ag
Synthetic resin
Families Citing this family (10)
* Cited by examiner, † Cited by third party
Publication number
Priority date
Publication date
Assignee
Title
WO1990006130A1
(en)
*
1988-11-30
1990-06-14
Biomedical Research Institute
A novel malarial sporozoite and exoerythrocytic peptide antigen
DE3841091A1
(en)
*
1988-12-07
1990-06-13
Behringwerke Ag
SYNTHETIC ANTIGENS, METHOD FOR THEIR PRODUCTION AND THEIR USE
DE68907045T2
(en)
*
1989-01-17
1993-12-02
Eniricerche Spa
Synthetic peptides and their use as general carriers for the preparation of immunogenic conjugates suitable for the development of synthetic vaccines.
NZ233255A
(en)
*
1989-04-11
1993-02-25
Chiron Corp
Plasmodium cs protein analogues lacking one or more of the repeat epitopes, and containing at least one nonrepeat flanking epitope
IT1237764B
(en)
*
1989-11-10
1993-06-17
Eniricerche Spa
SYNTHETIC PEPTIDES USEFUL AS UNIVERSAL CARRIERS FOR THE PREPARATION OF IMMUNOGENIC CONJUGATES AND THEIR USE FOR THE DEVELOPMENT OF SYNTHETIC VACCINES.
WO1991008756A1
(en)
*
1989-12-12
1991-06-27
Biomedical Research Institute
Novel malarial sporozoite peptide antigens
CA2047073A1
(en)
*
1990-07-19
1992-01-20
William J. Leanza
Coconjugate vaccines comprising immunogenic protein, hiv related peptides, and anionic moieties
NZ239643A
(en)
*
1990-09-17
1996-05-28
North American Vaccine Inc
Vaccine containing bacterial polysaccharide protein conjugate and adjuvant (c-nd-che-a-co-b-r) with a long chain alkyl group.
CA2125467C
(en)
*
1993-07-06
2001-02-06
Heinz Dobeli
Process for producing hydrophobic polypeptides, proteins or peptides
EP2086577B1
(en)
*
2006-10-16
2013-03-27
The Government of the United States of America as represented by the Secretary of the Department of Health and Human Services
Conjugates of the plasmodium falciparum surface protein pfs25 as malaria vaccine
Family Cites Families (5)
* Cited by examiner, † Cited by third party
Publication number
Priority date
Publication date
Assignee
Title
US4707357A
(en)
*
1984-06-26
1987-11-17
The United States Of America As Represented By The Secretary Of The Army
Immunologically active peptides capable of inducing immunization against malaria and genes encoding therefor
ZA855232B
(en)
*
1984-07-23
1986-02-26
Univ New York
Protective peptide antigen corresponding to plasmodium falciparum circumsporozoite protein
ES8800273A1
(en)
*
1985-03-28
1987-11-01
Univ New York
Immunogenic antigen-carrier protein conjugate for use in a vaccine against malaria.
IT1187710B
(en)
*
1985-07-25
1987-12-23
Eniricerche Spa
USEFUL PEPTIDAL COMPOSITION FOR THE PREPARATION OF MALARIA VACCINES AND DIAGNOSTIC KITS FOR THE DETERMINATION OF MALARIC DISEASES
US4693994A
(en)
*
1985-11-19
1987-09-15
The Government Of The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services
Protective synthetic peptide against malaria and encoding gene
1988
1988-02-01
EP
EP88300813A
patent/EP0289110A3/en
not_active
Ceased
1988-02-01
CA
CA000557889A
patent/CA1329124C/en
not_active
Expired – Fee Related
1988-02-02
AU
AU11188/88A
patent/AU624324B2/en
not_active
Ceased
Cited By (1)
* Cited by examiner, † Cited by third party
Publication number
Priority date
Publication date
Assignee
Title
AU615181B2
(en)
*
1987-03-30
1991-09-26
Novartis Ag
Synthetic resin
Also Published As
Publication number
Publication date
EP0289110A2
(en)
1988-11-02
EP0289110A3
(en)
1990-01-24
AU624324B2
(en)
1992-06-11
CA1329124C
(en)
1994-05-03
Similar Documents
Publication
Publication Date
Title
EP0383833A4
(en)
1990-11-07
Vaccines for malaria
AU6893287A
(en)
1987-08-14
Sustained release pharmaceutical preparation
GB8907914D0
(en)
1989-05-24
Vaccine preparation
HUT64480A
(en)
1994-01-28
An improved vaccine of meningococcus-polysaccharide conjugate
AU7169187A
(en)
1987-10-09
Nifedipine combination preparation
AU1090288A
(en)
1988-08-11
Novel polyamine derivatives
AU628149B2
(en)
1992-09-10
Coccidiosis vaccine
AU1354388A
(en)
1988-09-22
Vaccine against pasteurella
AU2233488A
(en)
1989-03-23
Mycoplasma vaccine
AU1118888A
(en)
1988-08-04
Conjugate malaria vaccine
AU1024388A
(en)
1988-07-21
Protein copolymer malaria vaccine
AU5449590A
(en)
1990-11-29
Anti-hiv drug
AU3706989A
(en)
1990-01-04
Coccidiosis vaccine
AU1489188A
(en)
1988-11-02
Novel vaccines
AU8204887A
(en)
1988-06-09
Conjugate vaccine
ZA88197B
(en)
1989-03-29
Protein copolymer malaria vaccine
AU6777490A
(en)
1991-06-13
Malaria vaccine
AU7395987A
(en)
1987-11-24
Vaccine
AU2187788A
(en)
1989-06-15
Antimalaria vaccines
AU2431388A
(en)
1989-05-04
Somototropin formulations
AU7713387A
(en)
1988-02-18
Hepatitis vaccine
AU2609488A
(en)
1989-06-01
Emulsifiers
AU1349588A
(en)
1988-09-26
Synthetic anti-caries vaccine
AU5450590A
(en)
1990-11-08
Malaria vaccine
AU7453687A
(en)
1988-01-07
Novel vaccines
None